---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-25-000041"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2025-07-11T23:59:59+00:00"
generated_at: "2026-05-18T07:02:47.775185+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Merit Medical names Martha Aronson as CEO effective Oct 3; preliminary Q2 revenue up ~12-14% YoY

## Summary
- Martha Aronson appointed President and CEO effective Oct 3, 2025; founder Fred Lampropoulos remains Chairman.
- Aronson previously EVP & President of Global Healthcare at Ecolab; 20 years at Medtronic.
- Compensation: $1M base salary, $250K signing bonus, target bonus 100% of base, $5.5M initial LTI award, $4.125M equity grant.
- Preliminary Q2 2025 revenue $380-384M, up 12-14% YoY; constant currency up 11-13%.
- Full Q2 earnings release scheduled for July 30, 2025 after market close.

## SEC filing metadata
- accession: 0000856982-25-000041
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2025-07-11T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698225000041/0000856982-25-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698225000041/mmsi-20250707x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-25-000041
- JSON: https://secwatch.observer/filing/0000856982-25-000041.json
- Plain text: https://secwatch.observer/filing/0000856982-25-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.